Workflow
GLP-1 obesity pills face off in head-to-head trial
CNBC Televisionยท2025-09-12 16:29

Welcome back. The next battle shaping up between Eli Lily and Novo Nordisk when it comes to GLP1s, the pills. Angelica Peoples with the story. Angelica.Hey Sarah. Well, that's right. Pills are the next frontier and it's changed a little bit over the last few months.So, Lily was getting all the attention here because its pill is easier to make and it's more convenient to take. But investors are now giving Novo a closer look after Lily's pill produced less weight loss than hoped in a recent trial. So, which p ...